Ra Capital Management, Director: Dice Therapeutics DICE Buy · Filed 23/03/27

Trade details

Type: Insider buy
Amount: $5,168,041.45
Shares · price: 192,335 sh · $26.87 a share
Held after: 6,409,928 sh
Stock: Dice Therapeutics DICE
Person: Ra Capital ManagementDirector
Trade date: 23/03/24
Filed: 23/03/27
Days to filing: 3 days

5 insiders bought this week

Insiders buying this week: 5 insiders
Holding change: +3.1%

Dice Therapeutics trades, last 26 weeks

What else happened in Dice Therapeutics around then

Filed or reported within 30 days of the trade day · 23/02/22~23/04/23

Ra Capital Management's recent trades

Ra Capital ManagementDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
Ra Capital ManagementDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
Ra Capital Management10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$136.2K
389,216 sh
$136.2K
Filed 06/22
Traded 06/17
Ra Capital Management10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$9,693
27,695 sh
$9,693
Filed 06/22
Traded 06/17
Ra Capital Management10% Owner
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.5M
61,523 sh
$1.5M
Filed 06/17
Traded 06/16

Ra Capital Management, Director — bought $5.2M of Dice Therapeutics DICE · 192,335 sh @ $26.87 | Whalegun